The Journal of Urology · 2005 · 508 citations · 22 references
MedicinePharmacologyUrologyNeurourologySensory PhysiologyUrodynamicsBladder DysfunctionBotulinum Toxin TherapyBotulinum Toxin TreatmentDetrusor OveractivityNeurogenic BladderNeurogenic Bladder DysfunctionBladder Overactivity TreatmentDetrusor Overactivity ManagementIntradetrusor Botulinum Toxin InjectionIntradetrusor Botulinum Toxin TherapyNeurogenic Bladder Afferent DysfunctionNeurogenic Detrusor DysfunctionPeripheral Sensory ReceptorsPresynaptic Signaling
PURPOSE: Botulinum neurotoxin type A (BoNT/A) is effective in the treatment of intractable detrusor overactivity (DO). In addition to its known inhibitory effect on presynaptic release of acetylcholine by motor terminals, there is increasing evidence that BoNT/A may affect sensory fibers. We investigated a possible effect of BoNT/A on human bladder afferent mechanisms by studying the sensory receptors P2X3 and TRPV1 in biopsies from patients with neurogenic or idiopathic DO. MATERIALS AND METHODS: A total of 38 patients (22 with neurogenic DO, 16 with idiopathic DO) with intractable DO were treated with intradetrusor BoNT/A, and bladder biopsies were taken at 4 and 16 weeks. Urodynamics and voiding diary were also recorded. Specimens were studied immunohistochemically for P2X3, TRPV1 and the pan-neuronal marker PGP9.5, in comparison with controls. RESULTS: P2X3-immunoreactive and TRPV1-immunoreactive (-IR) fibers were decreased at 4 weeks after BoNT/A, and more significantly at 16 weeks (paired t test p=0.0004 and p=0.0008, respectively), when significant improvements were observed in clinical and urodynamic parameters. P2X3-IR fiber decrease was significantly correlated with reduction of urgency episodes at 4 and 16 weeks (p=0.0013 at 4 weeks and p=0.02 at 16 weeks), but not maximum cystometric capacity or detrusor pressures. TRPV1-IR fiber decrease showed a similar trend. PGP9.5-IR suburothelial fibers remained unchanged after treatment at both followups (p=0.85 and p=0.21 at 4 and 16 weeks, respectively). Urothelial cell P2X3-IR and TRPV1-IR also appeared unchanged. CONCLUSIONS: Decreased levels of sensory receptors P2X3 and/or TRPV1 may contribute to the clinical effect of BoNT/A in detrusor overactivity.
22
Urinary bladder hyporeflexia and reduced pain-related behaviour in P2X3-deficient mice
Debra A. Cockayne, Sara G. Hamilton, Quan‐Ming Zhu et al. · Nature · 2000 · 1K citations
Medicine, Physiology, Urology +15
Altered urinary bladder function in mice lacking the vanilloid receptor TRPV1
Lori A. Birder, Y. Nakamura, Susanna Kiss et al. · Nature Neuroscience · 2002 · 695 citations
Medicine, Physiology, Urology +14
Subcutaneous administration of botulinum toxin A reduces formalin-induced pain
Minglei Cui, Sid Khanijou, John Rubino et al. · Pain · 2003 · 674 citations
Medicine, Neurobiology, Pharmacology +16